Beta Bionics, Inc. (BBNX) vs Cytek Biosciences, Inc. (CTKB)
- Beta Bionics, Inc. BBNX 16.35 −5.55%
- Cytek Biosciences, Inc. CTKB 5.24 −3.14%
Beta Bionics, Inc. and Cytek Biosciences, Inc. are both Medical Devices companies. Beta Bionics, Inc. is the larger, with a market value of $933.8M against $703.2M — 1.3× the size. Beta Bionics, Inc. grew revenue faster over the last twelve months: 52.5% against 5.44%. Cytek Biosciences, Inc. has the higher net margin (−39.0% vs −61.3%) and the higher return on invested capital (−46.4% vs −68.5%). Across the 17 metrics below, Cytek Biosciences, Inc. leads on 10 and Beta Bionics, Inc. on 7.
Valuation
Profitability
| Metric | BBNX | CTKB | Medical Devices median |
|---|---|---|---|
| Gross margin | 58.31% | 53.23% | 56.01% |
| Operating margin | (69.75%) | (21.60%) | (15.03%) |
| Net margin | (61.32%) | (38.98%) | (20.40%) |
| Free cash flow margin | (284.13%) | (5.79%) | (7.24%) |
| Return on equity | (26.16%) | (23.04%) | (15.32%) |
| Return on assets | (23.45%) | (17.14%) | (19.72%) |
| Return on invested capital | (68.47%) | (46.36%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack